C. Tropé

1.3k total citations
44 papers, 1.0k citations indexed

About

C. Tropé is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, C. Tropé has authored 44 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Reproductive Medicine, 14 papers in Obstetrics and Gynecology and 11 papers in Oncology. Recurrent topics in C. Tropé's work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (13 papers) and BRCA gene mutations in cancer (4 papers). C. Tropé is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (13 papers) and BRCA gene mutations in cancer (4 papers). C. Tropé collaborates with scholars based in Norway, Sweden and Belgium. C. Tropé's co-authors include Kolbein Sundfør, Heidi Lyng, J. Kærn, E K Rofstad, Christian Marth, Einar K. Rofstad, Vera M. Abeler, Marit Scheistrøen, Ignace Vergote and Mathias Onsrud and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and British Journal of Cancer.

In The Last Decade

C. Tropé

43 papers receiving 971 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Tropé Norway 19 425 380 263 219 215 44 1.0k
N. Einhorn Sweden 15 559 1.3× 285 0.8× 317 1.2× 100 0.5× 199 0.9× 35 967
Tetsuji Kurokawa Japan 20 499 1.2× 508 1.3× 259 1.0× 126 0.6× 176 0.8× 76 1.2k
S. Pecorelli Italy 4 895 2.1× 460 1.2× 456 1.7× 137 0.6× 284 1.3× 4 1.2k
J. F. Pringle Canada 18 355 0.8× 365 1.0× 363 1.4× 247 1.1× 480 2.2× 22 1.3k
Helen A. Bean Canada 13 394 0.9× 343 0.9× 325 1.2× 178 0.8× 258 1.2× 23 1.1k
Cecelia H. Boardman United States 14 351 0.8× 531 1.4× 279 1.1× 142 0.6× 434 2.0× 22 1.2k
Soon‐Beom Kang South Korea 24 692 1.6× 778 2.0× 223 0.8× 181 0.8× 354 1.6× 64 1.5k
W Gajewski United States 17 1.1k 2.6× 614 1.6× 442 1.7× 302 1.4× 279 1.3× 32 1.7k
Albert Steren United States 13 339 0.8× 259 0.7× 184 0.7× 71 0.3× 259 1.2× 21 726
Chad A. Hamilton United States 11 500 1.2× 504 1.3× 117 0.4× 113 0.5× 290 1.3× 26 1.0k

Countries citing papers authored by C. Tropé

Since Specialization
Citations

This map shows the geographic impact of C. Tropé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Tropé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Tropé more than expected).

Fields of papers citing papers by C. Tropé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Tropé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Tropé. The network helps show where C. Tropé may publish in the future.

Co-authorship network of co-authors of C. Tropé

This figure shows the co-authorship network connecting the top 25 collaborators of C. Tropé. A scholar is included among the top collaborators of C. Tropé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Tropé. C. Tropé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Paulsen, Torbjørn, J. Kærn, Kristina Kjærheim, C. Tropé, & Steinar Tretli. (2004). Symptoms and referral of women with epithelial ovarian tumors. International Journal of Gynecology & Obstetrics. 88(1). 31–37. 18 indexed citations
2.
Kristensen, Gunnar B., Wanja Kildal, Renate Pettersen, et al.. (2000). High-resolution Image Analysis - A Better Method for Predicting Prognosis in Early Ovarian Cancer. Gynecologic Oncology. 76(2). 236–236. 2 indexed citations
3.
Sundfør, Kolbein, Heidi Lyng, C. Tropé, & Einar K. Rofstad. (2000). Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: relationships to pretreatment tumor oxygenation and vascularization. Radiotherapy and Oncology. 54(2). 101–107. 88 indexed citations
4.
Rofstad, E K, Kolbein Sundfør, Heidi Lyng, & C. Tropé. (2000). Hypoxia-induced treatment failure in advanced squamous cell carcinoma of the uterine cervix is primarily due to hypoxia-induced radiation resistance rather than hypoxia-induced metastasis. British Journal of Cancer. 83(3). 354–359. 163 indexed citations
5.
Tropé, C., Christian Marth, & J. Kærn. (2000). Tamoxifen in the treatment of recurrent ovarian carcinoma. European Journal of Cancer. 36. 59–61. 46 indexed citations
6.
Piccart, Martine, Gavin Stuart, Jim Cassidy, et al.. (1999). Intergroup collaboration in ovarian cancer: a giant step forward. Annals of Oncology. 10. S83–S86. 13 indexed citations
7.
Dørum, Anne, Pål Møller, Erik-Jan Kamsteeg, et al.. (1997). A BRCA1 founder mutation, identified with haplotype analysis, allowing genotype/phenotype determination and predictive testing. European Journal of Cancer. 33(14). 2390–2392. 21 indexed citations
8.
Skomedal, Hanne, et al.. (1997). TP53 protein accumulation and gene mutation in relation to overexpression of MDM2 protein in ovarian borderline tumours and stage I carcinomas. The Journal of Pathology. 181(2). 158–165. 44 indexed citations
9.
Kristensen, Gunnar B., et al.. (1997). An Evaluation of Prognostic Factors in Uterine Carcinosarcoma. Gynecologic Oncology. 67(3). 316–321. 32 indexed citations
10.
Tropé, C., J. Kærn, Ignace Vergote, et al.. (1997). Randomized trial on adjuvant carboplatin versus no treatment in stage I high risk ovarian cancer by th Nordic Ovarian Cancer Study Group (NOCOVA). 16. 8 indexed citations
11.
Tropé, C., J. Kærn, & Ignace Vergote. (1997). Adjuvant Therapy for Early-Stage Epithelial Ovarian Cancer. 41–63. 1 indexed citations
12.
Kærn, J., et al.. (1996). Cisplatin/5-Fluorouracil Treatment of Recurrent Cervical Carcinoma: A Phase II Study with Long-Term Follow-up. Gynecologic Oncology. 60(3). 387–392. 27 indexed citations
13.
Piene, H., et al.. (1994). Improving the Quality of Anti-emetic Therapy. International Journal for Quality in Health Care. 6(1). 37–40.
14.
Vergote, Ignace, et al.. (1992). Hexamethylmelamine as second-line therapy in platin-resistant ovarian cancer. Gynecologic Oncology. 47(3). 282–286. 50 indexed citations
15.
Vergote, Ignace, et al.. (1992). CA125 and Placental Alkaline Phosphatase as Serum Tumor Markers in Epithelial Ovarian Carcinoma. Tumor Biology. 13(3). 168–174. 15 indexed citations
16.
Makar, Amin, et al.. (1992). CA 125 measured before second-look laparotomy is an independent prognostic factor for survival in patients with epithelial ovarian cancer. Gynecologic Oncology. 45(3). 323–328. 16 indexed citations
17.
Kærn, J., C. Tropé, Vera M. Abeler, T Iversen, & Knut E. Kjørstad. (1990). A Phase II Study of 5-Fluorouracil/Cisplatinum in Recurrent Cervical Cancer. Acta Oncologica. 29(1). 25–28. 19 indexed citations
18.
Lindahl, B, Per Alm, Mårten Fernö, et al.. (1989). Prognostic Value of Steroid Receptor Concentration and Flow Cytometrical Dna Measurements in Stage I-Ii Endometrial Carcinoma. Acta Oncologica. 28(4). 595–599. 8 indexed citations
19.
Wahlberg, Peter, Göran Fex, Anders Biörklund, C. Tropé, & Roger Wïllén. (1988). Quantitation and localization of cellular retionol‐binding protein in squamous‐cell carcinomas of the cervix uteri and of the oral cavity. International Journal of Cancer. 41(5). 771–776. 8 indexed citations
20.
Wennerberg, Johan, Roger Wïllén, & C. Tropé. (1988). Changes in Histology and Cell Kinetics During the Growth Course of Xenografted Squamous Cell Carcinoma. Archives of Otolaryngology - Head and Neck Surgery. 114(7). 781–787. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by N. Einhorn Breakdown of academic impact, for papers by Tetsuji Kurokawa Breakdown of academic impact, for papers by S. Pecorelli Breakdown of academic impact, for papers by J. F. Pringle Breakdown of academic impact, for papers by Helen A. Bean Breakdown of academic impact, for papers by Cecelia H. Boardman Breakdown of academic impact, for papers by Soon‐Beom Kang Breakdown of academic impact, for papers by W Gajewski Breakdown of academic impact, for papers by Albert Steren Breakdown of academic impact, for papers by Chad A. Hamilton
Rankless by CCL
2026